PLACE Trial: Preserving Long-Acting Contraception Through Education
Recruiting
N/A
Interventional Study
Contraception
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 – 49
- Sex
- Female
- Study type
- Interventional
- Purpose
- Health Services Research
- Participants needed
- 900 (estimated)
- Sponsor
- Pakistan Institute of Medical Sciences · Government
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Study Overview Summary
This randomized controlled trial will evaluate the effectiveness of structured counseling in improving the continuation rates of long-acting reversible contraception (LARC) among women in Islamabad, Pakistan, who present to family planning clinics for early removal of their contraception devices (copper-T IUD or Jadelle implant). The study, starting December 15, 2025, will …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Women presenting at the clinics exclusively for removal of a copper-T IUD or Jadelle subdermal implant within 2 years of use and within the first 2 months of the study.
Exclusion Criteria:
* Women not wishing to participate or unable to provide informed consent.
Contacts